JP Morgan Chase’s PharMerica Corporation PMC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-427,453
| Closed | -$12.5M | – | 5713 |
|
|
2017
Q3 | $12.5M | Buy |
427,453
+188,163
| +79% | +$5.27M | ﹤0.01% | 1821 |
|
|
2017
Q2 | $6.28M | Sell |
239,290
-31,479
| -12% | -$774K | ﹤0.01% | 2322 |
|
|
2017
Q1 | $6.34M | Buy |
270,769
+16,613
| +7% | +$410K | ﹤0.01% | 2270 |
|
|
2016
Q4 | $6.39M | Buy |
254,156
+16,761
| +7% | +$423K | ﹤0.01% | 2255 |
|
|
2016
Q3 | $6.66M | Buy |
237,395
+3,200
| +1% | +$82K | ﹤0.01% | 2043 |
|
|
2016
Q2 | $5.78M | Sell |
234,195
-453,200
| -66% | -$11.2M | ﹤0.01% | 2191 |
|
|
2016
Q1 | $15.2M | Buy |
687,395
+36,800
| +6% | +$979K | ﹤0.01% | 1516 |
|
|
2015
Q4 | $22.8M | Buy |
650,595
+335,822
| +107% | +$10.5M | 0.01% | 1245 |
|
|
2015
Q3 | $8.96M | Buy |
314,773
+290,903
| +1,219% | +$9.77M | ﹤0.01% | 1846 |
|
|
2015
Q2 | $795K | Buy |
23,870
+2,255
| +10% | +$69.2K | ﹤0.01% | 3385 |
|
|
2015
Q1 | $609K | Sell |
21,615
-55,776
| -72% | -$1.39M | ﹤0.01% | 3458 |
|
|
2014
Q4 | $1.6M | Sell |
77,391
-432,117
| -85% | -$10.3M | ﹤0.01% | 3085 |
|
|
2014
Q3 | $12.4M | Sell |
509,508
-188,048
| -27% | -$4.99M | ﹤0.01% | 1773 |
|
|
2014
Q2 | $19.9M | Buy |
697,556
+648,159
| +1,312% | +$18M | 0.01% | 1357 |
|
|
2014
Q1 | $1.38M | Sell |
49,397
-25,917
| -34% | -$636K | ﹤0.01% | 2717 |
|
|
2013
Q4 | $1.62M | Sell |
75,314
-13,306
| -15% | -$242K | ﹤0.01% | 2887 |
|
|
2013
Q3 | $1.18M | Buy |
88,620
+11,277
| +15% | +$152K | ﹤0.01% | 3165 |
|
|
2013
Q2 | $1.07M | Buy |
+77,343
| New | +$1.1M | ﹤0.01% | 3222 |
|
JP Morgan Chase's PMC Position: Q4 2017 in Review
JP Morgan Chase sold out of PharMerica Corporation (PMC) in Q4 2017, closing a stake of 427,453 shares — an estimated $12.5M sold.
JP Morgan Chase first reported a position in PMC in Q2 2013 and held it in 18 quarters. The position peaked at $22.8M in Q4 2015. 0 funds tracked by Wall St. Rank hold PMC as of Q4 2017.
- JP Morgan Chase reported no remaining PharMerica Corporation position as of Q4 2017 after selling out during the quarter.
- JP Morgan Chase sold 427,453 PharMerica Corporation shares in Q4 2017, an estimated $12.5M.
- JP Morgan Chase first reported a position in PharMerica Corporation in Q2 2013 and held it in 18 quarters.
- JP Morgan Chase's PharMerica Corporation position peaked at $22.8M in Q4 2015.
- 0 funds tracked by Wall St. Rank held PharMerica Corporation as of Q4 2017.
Based on JP Morgan Chase's 13F filing for Q4 2017, filed 13 Feb 2018.